BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34990618)

  • 21. Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer.
    Li H; Wang Z; Zhang W; Qian K; Xu W; Zhang S
    Cancer Lett; 2016 Jan; 370(1):39-55. PubMed ID: 26458995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
    Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
    J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein.
    Sheng W; Dong M; Chen C; Li Y; Liu Q; Dong Q
    Oncotarget; 2017 Feb; 8(9):14359-14373. PubMed ID: 27092875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT.
    Wang J; Cai H; Liu Q; Xia Y; Xing L; Zuo Q; Zhang Y; Chen C; Xu K; Yin P; Chen T
    Am J Chin Med; 2020; 48(3):703-718. PubMed ID: 32329642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling.
    Zhang J; Shao X; Sun H; Liu K; Ding Z; Chen J; Fang L; Su W; Hong Y; Li H; Li H
    Oncotarget; 2016 Sep; 7(38):61036-61053. PubMed ID: 27506933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling.
    Tian J; Yuan L
    Biomed Pharmacother; 2018 Oct; 106():109-116. PubMed ID: 29957460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
    Bi YL; Min M; Shen W; Liu Y
    Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of the RhoA/ROCK/AKT/β-catenin pathway by arginine-specific ADP-ribosytransferases 1 promotes migration and epithelial-mesenchymal transition in colon carcinoma.
    Song GL; Jin CC; Zhao W; Tang Y; Wang YL; Li M; Xiao M; Li X; Li QS; Lin X; Chen WW; Kuang J
    Int J Oncol; 2016 Aug; 49(2):646-56. PubMed ID: 27277835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
    Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
    Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolites of intestinal microflora upregulate miR-192-5p to suppress proliferation of colon cancer cells via RhoA-ROCK-LIMK2 pathway.
    Huang YL; Li XH; Ma H; Yue HY; Hu XY
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1794-1806. PubMed ID: 32141548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PRP4 kinase induces actin rearrangement and epithelial-mesenchymal transition through modulation of the actin-binding protein cofilin.
    Islam SU; Ahmed MB; Lee SJ; Shehzad A; Sonn JK; Kwon OS; Lee YS
    Exp Cell Res; 2018 Aug; 369(1):158-165. PubMed ID: 29787735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade.
    He M; Cheng Y; Li W; Liu Q; Liu J; Huang J; Fu X
    BMC Cancer; 2010 Apr; 10():170. PubMed ID: 20429915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer.
    Zeng Y; Xie H; Qiao Y; Wang J; Zhu X; He G; Li Y; Ren X; Wang F; Liang L; Ding Y
    Cancer Sci; 2015 Oct; 106(10):1385-93. PubMed ID: 26258642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rhophilin-associated tail protein 1 promotes migration and metastasis in triple negative breast cancer via activation of RhoA.
    Liu Q; Huang X; Li Q; He L; Li S; Chen X; Ouyang Y; Wang X; Lin C
    FASEB J; 2020 Aug; 34(8):9959-9971. PubMed ID: 32427399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-31-5p promotes the cell growth, migration and invasion of colorectal cancer cells by targeting NUMB.
    Peng H; Wang L; Su Q; Yi K; Du J; Wang Z
    Biomed Pharmacother; 2019 Jan; 109():208-216. PubMed ID: 30396078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cooperation of SRPK2, Numb and p53 in the malignant biology and chemosensitivity of colorectal cancer.
    Wang G; Sheng W; Tang J; Li X; Zhou J; Dong M
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31898732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation and mRNA splicing of collapsin response mediator protein-2 determine inhibition of rho-associated protein kinase (ROCK) II function in carcinoma cell migration and invasion.
    Morgan-Fisher M; Couchman JR; Yoneda A
    J Biol Chem; 2013 Oct; 288(43):31229-40. PubMed ID: 24036111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer.
    Kim JH; Hwang YJ; Han SH; Lee YE; Kim S; Kim YJ; Cho JH; Kwon KA; Kim JH; Kim SH
    World J Gastroenterol; 2015 Sep; 21(34):9887-99. PubMed ID: 26379394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of GNL3 expression promotes colon cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
    Tang X; Zha L; Li H; Liao G; Huang Z; Peng X; Wang Z
    Oncol Rep; 2017 Oct; 38(4):2023-2032. PubMed ID: 28849076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.